Financial Framework 2024/25
On 26th September 2024, the CPS Board agreed to what was considered an “adequate” deal from the Scottish Government. This agreement provides a 6% uplift on the Global Sum, ensuring stability and predictability for the community pharmacy network, the Scottish Government, and NHS Health Boards. It also allows adequate time and space to develop and embed pharmaceutical care services. This has enabled the negotiating team to work with the Scottish Government to finalise this year's financial package.
The package outlines a defined amount of funding (Remuneration) available for the provision of core services, referred to as the Global Sum, from which all contractors will benefit. We will explain these funding "pots" later.
There are, however, small elements of our national funding that do not fall within the Global Sum. For example, not all contractors will need to take advantage of the arrangements for stoma dispensing, and Medicines Complete access, which are technically contracts in their own right. Collectively, we refer to these as the “Non-Global Sum”.
The financial package also details the arrangements for the Reimbursement element of the annual agreement—specifically, the conditions around funding received from purchasing certain medicines for less than what the NHS pays us for them.
For a breakdown of each element please see below:
As touched on in the introduction to pharmacy funding, part of a pharmacy’s income is dependent on the money made on part 7 drug tariff medicines they source and provide on prescription – this profit is often referred to as the margin
Advance payments are made to support contractor cashflow while actual payment for the prescriptions submitted is calculated.
Over the years as the pharmacy contract has changed, different service payments have been joined together into what we now call the Establishment Payment.
The Pharmaceutical Needs Weighting Payment (PNWP) makes the payment for the additional pharmaceutical needs (and associated workload) from age and deprivation characteristics of the people using the pharmacy.
The Service Efficiency Payment is for achieving a target level of electronic claiming for prescriptions submitted for pricing by Practitioner Services.
Quality and Service Development supports the operation of a service for coeliac patients and the development of a safety culture
The payments for MCR are made using one of the more complex models in our financial package and is based on the number of people registered for the service (capitation model) at the end of a given month.
Base payment of £1,000 and an activity payment from the activity payment pot of £1.308m where their activity level is above a specified minimum of 100.
A monthly fee of £3,000 will be made to the contractor named on the Board’s pharmaceutical list at the 1st day of that month for each full month the service is made available in the community pharmacy.
Scottish Government has agreed to an annualised pool of £1m to support the training of employee Pharmacist Independent Prescribers in community pharmacies.
To support the Post Registration National Foundation Programme for Newly Qualified Pharmacists, a monthly fee of £1,000 will be made available to the contractor named on the pharmaceutical list on the 1st of each month where the newly qualified pharmacist has joined the PRFP scheme.
The Scottish Government campaign activity for 2024-25 is currently being finalised and a more detailed list for the year will be issued in due course.
The annualised pool of £3.58 million to recognise the work undertaken in the treatment of unscheduled care.
The total Establishment Payment plus Dispensing Pool Payment plus Pharmaceutical Needs Weighting Payment made to an Essential Small Pharmacy (ESP) each month, are subject to a guarantee minimum target income of £4,412 for full-time contractors.
Advance payments are made to support contractor cashflow while actual payment for the prescriptions submitted is calculated.